158 related articles for article (PubMed ID: 17107393)
1. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides.
Bellei B; Cota C; Amantea A; Muscardin L; Picardo M
Br J Dermatol; 2006 Dec; 155(6):1223-9. PubMed ID: 17107393
[TBL] [Abstract][Full Text] [Related]
2. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.
Cagatay T; Ozturk M
Oncogene; 2002 Nov; 21(52):7971-80. PubMed ID: 12439747
[TBL] [Abstract][Full Text] [Related]
3. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.
Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S
Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
[TBL] [Abstract][Full Text] [Related]
5. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas.
Bellei B; Pacchiarotti A; Perez M; Faraggiana T
Mod Pathol; 2004 Oct; 17(10):1275-81. PubMed ID: 15195109
[TBL] [Abstract][Full Text] [Related]
6. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
Chen Ban K; Singh H; Krishnan R; Fong Seow H
J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma].
Wu W; Zhang X; Yan X; Wang J; Zhang J; Li Y
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):264-7. PubMed ID: 12515622
[TBL] [Abstract][Full Text] [Related]
9. p53 oncoprotein expression in cutaneous lymphoproliferations.
Beylot-Barry M; Vergier B; DeMascarel A; Beylot C; Merlio JP
Arch Dermatol; 1995 Sep; 131(9):1019-24. PubMed ID: 7661603
[TBL] [Abstract][Full Text] [Related]
10. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
Lazar AJ; Calonje E; Grayson W; Dei Tos AP; Mihm MC; Redston M; McKee PH
J Cutan Pathol; 2005 Feb; 32(2):148-57. PubMed ID: 15606674
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.
Ragazzon B; Libé R; Gaujoux S; Assié G; Fratticci A; Launay P; Clauser E; Bertagna X; Tissier F; de Reyniès A; Bertherat J
Cancer Res; 2010 Nov; 70(21):8276-81. PubMed ID: 20959480
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
13. Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF.
Carbone A; Bernardini L; Valenzano F; Bottillo I; De Simone C; Capizzi R; Capalbo A; Romano F; Novelli A; Dallapiccola B; Amerio P
Genes Chromosomes Cancer; 2008 Dec; 47(12):1067-75. PubMed ID: 18663754
[TBL] [Abstract][Full Text] [Related]
14. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
15. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.
Ridgeway AG; McMenamin J; Leder P
Oncogene; 2006 Jun; 25(25):3518-27. PubMed ID: 16434961
[TBL] [Abstract][Full Text] [Related]
16. CD13 and TCR clone: markers of early mycosis fungoides.
Bernier C; Nguyen JM; Quéreux G; Renault JJ; Bureau B; Dreno B
Acta Derm Venereol; 2007; 87(2):155-9. PubMed ID: 17340024
[TBL] [Abstract][Full Text] [Related]
17. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
[TBL] [Abstract][Full Text] [Related]
18. p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan.
Hongyo T; Hoshida Y; Nakatsuka S; Syaifudin M; Kojya S; Yang WI; Min YH; Chan H; Kim CH; Harabuchi Y; Himi T; Inuyama M; Aozasa K; Nomura T
Oncol Rep; 2005 Feb; 13(2):265-71. PubMed ID: 15643509
[TBL] [Abstract][Full Text] [Related]
19. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
20. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
